[An evaluation of the safety, efficacy, clinical effectiveness, efficiency and organisational aspects of the implementation of model-based dosing systems for the treatment of inflammatory bowel disease]
Llinàs-Mallol L, Moreno-Lorente M, Domènech Morral E, Sánchez Hernández JG, Estrada Sabadell MD, Vivanco-Hidalgo RM
Record ID 32018015708
Spanish
Original Title:
Evaluación de la seguridad, la eficacia, la efectividad clínica, la eficiencia y los aspectos organizativos de la implementación de los sistemas de dosificación basada en modelos para el tratamiento de la enfermedad inflamatoria intestinal
Details
Project Status:
Completed
Year Published:
2026
URL for published report:
http://hdl.handle.net/11351/14343
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Spain
MeSH Terms
- Inflammatory Bowel Diseases
- Irritable Bowel Syndrome
- Infliximab
- Tumor Necrosis Factor Inhibitors
- Adalimumab
- Ustekinumab
- Biomarkers, Pharmacological
- Precision Medicine
- Decision Support Systems, Clinical
- Bayes Theorem
- Drug Monitoring
- Crohn Disease
- Colitis, Ulcerative
- Colitis
- Drug Dosage Calculations
Keywords
- Inflammatory Bowel Diseases
- Irritable Bowel Syndrome
- Drug Monitoring
- Decision Support Systems
- Bayes Theorem
- Infliximab
- Tumor Necrosis Factor Inhibitors
- Adalimumab
- Ustekinumab
- Biomarkers
- Precision Medicine
- Model-based dosing
- Biological drugs
Contact
Organisation Name:
Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
Contact Address:
Carrer d’Aragó, 330–332 (segona planta) 08009 Barcelona, Spain
Contact Email:
atiq.aquas@gencat.cat
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.